Taylor AJ - Search Results

1

Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial.

Lee JK, Grace KA, Taylor AJ. Lee JK, et al. Among authors: taylor aj. JAMA. 2006 Dec 6;296(21):2563-71. doi: 10.1001/jama.296.21.joc60162. Epub 2006 Nov 13. JAMA. 2006. PMID: 17101639 Clinical Trial.

2

Low cholesterol efflux capacity and abnormal lipoprotein particles in youth with type 1 diabetes: a case control study.

Gourgari E, Playford MP, Campia U, Dey AK, Cogen F, Gubb-Weiser S, Mete M, Desale S, Sampson M, Taylor A, Rother KI, Remaley AT, Mehta NN. Gourgari E, et al. Cardiovasc Diabetol. 2018 Dec 19;17(1):158. doi: 10.1186/s12933-018-0802-0. Cardiovasc Diabetol. 2018. PMID: 30567548 Free PMC article.

3

Meta-analysis of effect of single versus dual antiplatelet therapy on early patency of bypass conduits after coronary artery bypass grafting.

Nocerino AG, Achenbach S, Taylor AJ. Nocerino AG, et al. Among authors: taylor aj. Am J Cardiol. 2013 Nov 15;112(10):1576-9. doi: 10.1016/j.amjcard.2013.07.017. Epub 2013 Sep 13. Am J Cardiol. 2013. PMID: 24035160 Review.

4

Evidence to support aggressive management of high-density lipoprotein cholesterol: implications of recent imaging trials.

Taylor AJ. Taylor AJ. Am J Cardiol. 2008 Apr 17;101(8A):36B-43B. doi: 10.1016/j.amjcard.2008.02.030. Am J Cardiol. 2008. PMID: 18375240 Review.

5

Relationship between glycemic status and progression of carotid intima-media thickness during treatment with combined statin and extended-release niacin in ARBITER 2.

Taylor AJ, Zhu D, Sullenberger LE, Lee HJ, Lee JK, Grace KA. Taylor AJ, et al. Vasc Health Risk Manag. 2007;3(1):159-64. Vasc Health Risk Manag. 2007. PMID: 17583186 Free PMC article. Clinical Trial.

6

Design and rationale of the ARBITER 6 trial (Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol)-6-HDL and LDL Treatment Strategies in Atherosclerosis (HALTS).

Devine PJ, Turco MA, Taylor AJ. Devine PJ, et al. Among authors: taylor aj. Cardiovasc Drugs Ther. 2007 Jun;21(3):221-5. doi: 10.1007/s10557-007-6020-8. Cardiovasc Drugs Ther. 2007. PMID: 17404825 Clinical Trial.

7

The effect of 24 months of combination statin and extended-release niacin on carotid intima-media thickness: ARBITER 3.

Taylor AJ, Lee HJ, Sullenberger LE. Taylor AJ, et al. Curr Med Res Opin. 2006 Nov;22(11):2243-50. doi: 10.1185/030079906x148508. Curr Med Res Opin. 2006. PMID: 17076985 Clinical Trial.

8

Non-invasive atherosclerosis imaging: use to assess response to novel or combination lipid therapies.

Villines TC, Taylor AJ. Villines TC, et al. Among authors: taylor aj. Curr Drug Targets Cardiovasc Haematol Disord. 2005 Dec;5(6):557-64. doi: 10.2174/156800605774962059. Curr Drug Targets Cardiovasc Haematol Disord. 2005. PMID: 16503876 Review.

9

Marked low-density lipoprotein cholesterol reduction below current national cholesterol education program targets provides the greatest reduction in carotid atherosclerosis.

Kent SM, Coyle LC, Flaherty PJ, Markwood TT, Taylor AJ. Kent SM, et al. Among authors: taylor aj. Clin Cardiol. 2004 Jan;27(1):17-21. doi: 10.1002/clc.4960270105. Clin Cardiol. 2004. PMID: 14743850 Free PMC article. Clinical Trial.

10

Flushing and the HDL-C response to extended-release niacin.

Taylor AJ, Stanek EJ. Taylor AJ, et al. J Clin Lipidol. 2008 Aug;2(4):285-8. doi: 10.1016/j.jacl.2008.05.002. Epub 2008 May 16. J Clin Lipidol. 2008. PMID: 21291745

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results